75 Kenyans Die Daily From Cancer, Making It the Second Deadliest Disease in the Country

Cancer has emerged as Kenya’s silent killer, claiming 75 lives every single day and cementing its position as the second deadliest disease in the country after pneumonia.

This grim reality paints a picture of a healthcare system buckling under the weight of a crisis that touches every corner of Kenyan society.

The numbers are staggering.

According to the National Cancer Institute of Kenya, over 45,000 people receive a cancer diagnosis annually, while approximately 24,000 succumb to the disease.

These aren’t just statistics—they represent families torn apart, dreams cut short, and communities grappling with an epidemic that shows no signs of slowing down.

What makes this crisis particularly devastating is how it disproportionately affects women.

The Kenya National Bureau of Statistics’ 2024 Vital Statistics Report reveals that 4,498 out of 50,926 registered female deaths were attributed to cancer, making it the leading cause of death among Kenyan women.

This represents a dramatic shift from just three years ago when cancer ranked fifth among leading causes of death in health facilities.

Dr. Timothy Olweny, Chairperson of the Cancer Institute of Kenya’s Board of Trustees, doesn’t mince words about the underlying causes.

“There is a very distinct association between poverty and ill health, especially when it comes to cancer. I call it a bidirectional causality because poverty is a cause as well as a consequence of ill health,” he explains.

This observation cuts to the heart of Kenya’s healthcare inequality. While cancer doesn’t discriminate by social class, access to treatment certainly does.

The high cost of cancer drugs and unequal access to treatment create a two-tier system where survival often depends on one’s ability to pay rather than the severity of the disease.

The institutional response has been woefully inadequate.

The Cancer Institute of Kenya operates with just 30 employees when it requires 300 to effectively serve the country’s growing number of cancer patients.

This staffing crisis means that even when patients can afford treatment, the system often cannot provide it.

Environmental factors compound the problem. Dr. Elias Melly, the Institute’s Chief Executive Officer, points to widespread exposure to carcinogenic chemicals in homes and farms as a significant contributor to rising cancer rates.

“Chemical exposure is one of the leading causes of cancer. In our farms, in our communities, we need to have very dedicated strategies to make sure that all the chemicals identified to have carcinogenic effects are banned,” he emphasizes.

The gender dimension of Kenya’s cancer crisis cannot be ignored.

While men primarily die from pneumonia, cancer has become the leading killer of women.

This disparity suggests that gender-specific factors—whether biological, environmental, or social—are at play in cancer development and mortality patterns.

The recent Second National Cancer Summit brought together health stakeholders calling for urgent government intervention.

Their demands are clear: increased funding for cancer care services, stronger regulations on harmful substances, and investment in sustainable systems that would make treatment affordable and accessible to all Kenyans.

The Social Health Authority (SHA) has come under scrutiny as potentially part of the solution. Stakeholders believe that with proper reforms, SHA could make it easier for cancer patients to access drugs and treatment in public health facilities.

However, the authority’s effectiveness remains questionable given ongoing challenges with premium payments and coverage clarity.

Regional disparities add another layer of complexity to the crisis.

While Nairobi County issued the most death certificates in 2024 (16,306), rural counties like Samburu, Turkana, and Lamu issued far fewer, suggesting either better health outcomes or, more likely, underreporting due to limited healthcare infrastructure.

The human cost extends beyond the immediate victims. Cancer’s “bidirectional causality” with poverty means that families often fall into financial ruin trying to save their loved ones, creating a cycle where the disease perpetuates the very conditions that make it more likely to occur.

As Kenya grapples with this crisis, the path forward requires more than just medical intervention.

It demands a comprehensive approach that addresses environmental factors, strengthens healthcare infrastructure, ensures equitable access to treatment, and breaks the link between poverty and cancer mortality.

The 75 lives lost daily to cancer represent more than statistics—they are a call to action for a nation that cannot afford to lose any more of its people to a disease that, with proper resources and commitment, could be far more manageable.

Until then, cancer will continue its relentless march through Kenyan society, claiming lives that could have been saved and leaving behind families asking why their loved ones had to die from a disease that kills not just because of its biological nature, but because of systemic failures in healthcare delivery and social equity.